Similar real-world two-year visual acuity gains in treatment-naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti-vascular endothelial growth factor

Johanne Bjerre Lindboe*, Caroline Schmidt Laugesen, Torben Lykke Sørensen, Troels Brynskov

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

1 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftActa Ophthalmologica
Vol/bind99
Udgave nummer7
Sider (fra-til)1248-e1249
ISSN1755-375X
DOI
StatusUdgivet - 2021

Citationsformater